Monitoring and management of patients on therapeutic anticoagulation: A quality improvement initiative

Clear national and trust guidelines are available regarding the management of patients receiving anticoagulation therapy (warfarin and low molecular weight heparin (LMWH)). Lack of available evidence for LMWH in renal impairment makes anti-factor Xa monitoring crucial in this population. Two